Photo of Torunn  Yock, MD

Torunn Yock, MD

  • Director, Pediatric Radiation Oncology
  • Professor, Harvard Medical School
  • Chair, Radiation Oncology Quality Assurance

617-724-1836

Accepting New Patients

Visit my website Request a patient consultation

Overview

https://www.massgeneral.org/radiationoncology/

 

Departments

Radiation Oncology

Centers & Specialties

Cancer Center

MassGeneral Hospital for Children

Clinical Interests
  • Proton radiation therapy
  • Pediatric tumors
  • Pediatric oncology
  • Pediatric brain tumors
  • Pediatric malignancies
Medical Education
  • MD, Harvard Medical School
  • Residency, Massachusetts General Hospital
Board Certifications
  • Radiation Oncology
Locations
  • Boston: Massachusetts General Hospital
Insurances Accepted
  • Aetna Health Inc.
  • AllWays Health (NHP) - ACD
  • AllWays Health (NHP) - PBO
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • BMC HealthNet Mass Health MCO/ACO
  • Cigna (PAL #'s)
  • Commonwealth Care Alliance
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Maine Community Health Options (MCHO)
  • MassHealth
  • Medicare
  • Medicare - ACD
  • OSW - Connecticut
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - New York
  • OSW - Rhode Island
  • OSW - Vermont
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Railroad Medicare - ACD
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - PBO
  • Well Sense Pediatrics

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.

Patient Age Group
Pediatric and Adult
Provider Gender
Female

Biography

Doctor Torunn I. Yock is the Director of Pediatric Radiation Oncology, Chair of the Quality Improvement Committee in Radiation Oncology at Massachusetts General Hospital, and Professor at Harvard Medical School. She received her MD from Harvard Medical School and acquired a Masters in Community Health as a Fulbright Scholar from the University of New South Wales in Sydney, Australia.  Her residency was at Massachusetts General Hospital.  Her clinical practice is now comprised mostly of pediatric patients and survivors of childhood cancer.  Dr. Yock’s research career has focused on measuring health outcomes to further improve upon cure rates and the quality of the survivorship in pediatric cancer patients and applying big data principals to research repositories.  Her research has focused on the role of proton radiotherapy in pediatric cancer and both its power to mitigate late effects in our childhood cancer survivors, but also its potential pitfalls.  Dr. Yock is the Primary Investigator of multiple pediatric protocols and she holds grant funding from a variety of sources including the NCI.  She also participates in collaborative research with the Children’s Oncology Group, sitting on the Brain Tumor and Soft Tissue Sarcoma Committees, and is leading an NCI/MGH-sponsored multi-institutional registry enrolling pediatric patients treated with modern proton and photon radiotherapy and have accrued over 2600 patients. She has also authored over 120 articles and chapters and is an active member of ASTRO, ASCO, PROS, SIOP and serves on the American Board of Radiology to develop both the written and oral board examinations.

Research & Publications

Research Summary

View my most recent research

Dr. Yock is currently the director of Pediatric Radiation Oncology at Massachusetts General Hospital which is the largest pediatric proton program in the world, having treated over 1700 pediatric proton patients. As the primary investigator of 6 prospective proton protocols, her research focuses on quantifying the late effects and Health-Related Quality of Life in pediatric cancer patients treated with radiotherapy.  In addition, Dr. Yock is leading a successful multi-site pediatric  radiation registry, the Pediatric Proton/Photon Consoritum Registry (PPCR),  in which over 2600 patients have been enrolled and receives support from NCI, and internal funding and some industry support as well.   Dr. Yock's career has focused on measuring health outcomes to further improve upon cure rates and the quality of the survivorship in pediatric cancer patients and applying big data principles to research repositories.  Her research has focused on the role of proton radiotherapy in pediatric cancer and both its power to mitigate late effects in our childhood cancer survivors, but also its potential pitfalls. 

 Learn more about Dr. Yock's research.

Publications

View my most recent publications at PubMed

  1. Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Mar;17(3):287-98.

  2. Vatner RE, Niemierko A, Misra M, Weyman E, Goebel C, Ebb D, Jones R, Huang M, Mahajan A, Grosshans D, Paulino A, Stanley T, MacDonald SM, Tarbell NJ, Yock TI. Endocrine deficiency as a function of radiation dose to the hypothalamus and pituitary in pediatric and young adult patients with brain tumors.  J Clin Oncol. 2018 Oct 1;36(28):2854-2862. 

  3. Eaton BR, Esiashvili N, Kim S, Patterson B, Weyman EA, Thornton LT, Mazewski C, MacDonald TJ, Ebb D, MacDonald SM, Tarbell NJ, Yock TI. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol. 2016 Jun; 18(6): 881-7.

  4. Ladra ML, Szymonifka J, Mahajan A, Friedmann AM, Yeap BY, Goebel C, MacDonald SM, Grosshans D, Rodriguez-Galindo C, Marcus KJ, Tarbell NJ, Yock TI. Preliminary results of a Phase II Trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol. 2014 Nov 20;32(33):3762-70.

  5. Kuhlthau K, Pulsifer MB, Yeap BY, Morales DR, Delahaye J, Hill KS, Ebb D, Abram A, MacDonald SM, Tarbell NJ, Yock TI, A prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol. 2012 Jun 10;30(17):2079-86. PMID: 22565004  

News & Events

  • Coverage of study led by Torunn Yock, MD, MCH

    Compared with traditional photon radiotherapy, proton radiotherapy irradiates less normal tissue and might improve health outcomes associated with photon radiotherapy by reducing toxic effects to normal tissue. The investigators did a trial to assess late complications, acute side-effects, and survival associated with proton radiotherapy in children with medulloblastoma.

  • Proton therapy controls common pediatric brain tumor with fewer long-term side effects

    The use of proton radiotherapy to treat the most common malignant brain tumor in children is as effective as standard photon (x-ray) radiation therapy while causing fewer long-term side effects such as hearing loss and cognitive disorders, according to a study receiving online publication in Lancet Oncology.

  • Proton therapy controls common pediatric brain tumor with fewer long-term side effects

    The use of proton radiotherapy to treat medulloblastoma, the most common malignant brain tumor in children, is as effective as standard radiation therapy while causing fewer long-term side effects.

  • Charlie's Story: Instilling Confidence Through a High Standard of Care

    Charlie Beecher's family described the first two years of his life as joyously normal until Charlie developed belly pain. When they found out it was cancer, the Beechers brought Charlie to the Francis H. Burr Proton Therapy Center, which helped Charlie return to his normal, happy childhood.

  • Ryan's Story: Inspired by Compassionate Care to Achieve His Dreams

    When Ryan Schlosser received his master's degree this year, he thought of everyone who supported him along the way, especially his care team at the Francis H. Burr Proton Therapy Center at MGHfC, who played a larger role in his success than he ever imagined.

  • Alex's Story: Family-Centered Care Helps Kids Be Kids Throughout Challenging Treatments

    When Alex Sheehan was diagnosed with a brain tumor at age 10, staff at the Francis H. Burr Proton Therapy Center helped him simply be a kid during a challenging time.

  • Crushing Cancer

    After their 8-year-old son had a successful brain tumor surgery in their home state of Washington, Joe and Leigh McGraw chose to take Tommy to MassGeneral Hospital for Children's Francis H. Burr Proton Therapy Center for targeted treatment. The McGraw's share the story of their experience at MGHfC in the letter and video below.

Multimedia

  • Tommy's Story

    Tommy McGraw, 8 years old, received Proton Beam Therapy at Massachusetts General Hospital after having a brain tumor removed at their hometown hospital, Seattle Children’s Hospital.

Contact

Francis H. Burr Proton Therapy Center
55 Fruit Street
Boston, MA 02114-2696
Phone 1: 617-724-1836
Phone 2: 617-724-1583
Fax: 617-724-4808

Back to Top